Back to results
TerminatedPhase 3

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients

NCT02453386

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Birmingham, Alabama, United States

+70 additional locations

View on ClinicalTrials.gov
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients — TrialFind